DPP4 and obesity due to melanocortin 4 receptor deficiency: Limited information about is available regarding DPP4’s functions in humans, with the exception that plasma DPP4 activity has been shown to be increased in inflammation-related metabolic disorders (including obesity and diabetes) and carotid arterial atherosclerosis onset [18,19].